# LORATADINE
> **ANDA215127** · Abbreviated New Drug Application (Generic) · Sponsor: CATALENT PHARMA · Approved 2025-02-28
## Drug
- **FDA Application Number:** ANDA215127
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** LORATADINE
- **Generic name:** Loratadine
- **Active ingredients:** LORATADINE
- **Dosage form:** CAPSULE
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CATALENT PHARMA
- **First approval:** 2025-02-28
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215127)
---
*AI Analytics · CC0 1.0*